These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22330248)

  • 21. [Isolation, identification and genetic analysis of a murine norovirus strain].
    Yuan W; Zhang Y; Wang J; Liu XM; Zhao WB; Huang R
    Bing Du Xue Bao; 2014 Jul; 30(4):359-68. PubMed ID: 25272587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histologic Lesions Induced by Murine Norovirus Infection in Laboratory Mice.
    Hsu CC; Piotrowski SL; Meeker SM; Smith KD; Maggio-Price L; Treuting PM
    Vet Pathol; 2016 Jul; 53(4):754-63. PubMed ID: 26792844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet.
    Merat S; Casanada F; Sutphin M; Palinski W; Reaven PD
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1223-30. PubMed ID: 10323773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naturally occurring murine norovirus infection in a large research institution.
    Perdue KA; Green KY; Copeland M; Barron E; Mandel M; Faucette LJ; Williams EM; Sosnovtsev SV; Elkins WR; Ward JM
    J Am Assoc Lab Anim Sci; 2007 Jul; 46(4):39-45. PubMed ID: 17645294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr
    Zhao L; Cozzo AJ; Johnson AR; Christensen T; Freemerman AJ; Bear JE; Rotty JD; Bennett BJ; Makowski L
    Atherosclerosis; 2017 Nov; 266():182-189. PubMed ID: 29035781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathology of immunodeficient mice with naturally occurring murine norovirus infection.
    Ward JM; Wobus CE; Thackray LB; Erexson CR; Faucette LJ; Belliot G; Barron EL; Sosnovtsev SV; Green KY
    Toxicol Pathol; 2006; 34(6):708-15. PubMed ID: 17074739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a broadly reactive nested reverse transcription-PCR assay to detect murine noroviruses, and investigation of the prevalence of murine noroviruses in laboratory mice in Japan.
    Kitajima M; Oka T; Tohya Y; Katayama H; Takeda N; Katayama K
    Microbiol Immunol; 2009 Sep; 53(9):531-4. PubMed ID: 19703247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and evaluation of a broadly reactive reverse transcription recombinase polymerase amplification assay for rapid detection of murine norovirus.
    Ma L; Zeng F; Cong F; Huang B; Zhu Y; Wu M; Xu F; Yuan W; Huang R; Guo P
    BMC Vet Res; 2018 Dec; 14(1):399. PubMed ID: 30547776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting macrophage- and intestinal epithelial cell-specific microRNAs against norovirus restricts replication in vivo.
    Thorne L; Lu J; Chaudhry Y; Bailey D; Goodfellow I
    J Gen Virol; 2018 Dec; 99(12):1621-1632. PubMed ID: 29683421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection with the Persistent Murine Norovirus Strain MNV-S99 Suppresses IFN-Beta Release and Activation of Stat1 In Vitro.
    Niendorf S; Klemm U; Mas Marques A; Bock CT; Höhne M
    PLoS One; 2016; 11(6):e0156898. PubMed ID: 27294868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MNV primarily surveillance by a recombination VP1-derived ELISA in Beijing area in China.
    Xiang Z; Tian S; Tong W; Chang H; Su J; Zhang L; Liu X; Li Y; Wei Q; Liu Y
    J Immunol Methods; 2014 Jun; 408():70-7. PubMed ID: 24857757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
    Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
    Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
    Coenen KR; Hasty AH
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
    Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
    Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice.
    Krishack PA; Bhanvadia CV; Lukens J; Sontag TJ; De Beer MC; Getz GS; Reardon CA
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26187995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
    Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr(-/-) mice.
    Silva JC; César FA; de Oliveira EM; Turato WM; Tripodi GL; Castilho G; Machado-Lima A; de Las Heras B; Boscá L; Rabello MM; Hernandes MZ; Pitta MG; Pitta IR; Passarelli M; Rudnicki M; Abdalla DS
    Pharmacol Res; 2016 Feb; 104():49-60. PubMed ID: 26706782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Pelleting, Irradiation, and Autoclaving of Rodent Feed on MPV and MNV Infectivity.
    Adams SC; Myles MH; Tracey LN; Livingston RS; Schultz CL; Reuter JD; Leblanc M
    J Am Assoc Lab Anim Sci; 2019 Sep; 58(5):542-550. PubMed ID: 31391143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
    Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice.
    Out R; Hoekstra M; Hildebrand RB; Kruit JK; Meurs I; Li Z; Kuipers F; Van Berkel TJ; Van Eck M
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2295-300. PubMed ID: 16857950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.